Annex Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Annex Advisory Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4,728	Closed	-$208K	–	98
2013 Q4	$208K	Buy	+4,728	New	+$197K	0.08%	86

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Annex Advisory Services's XPH Position: Q1 2014 in Review

Annex Advisory Services sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2014, closing a stake of 4,728 shares — an estimated $208K sold.

Annex Advisory Services first reported a position in XPH in Q4 2013 and held it in 1 quarter. The position peaked at $208K in Q4 2013. 72 funds tracked by Wall St. Rank hold XPH as of Q1 2014.

Annex Advisory Services reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2014 after selling out during the quarter.
Annex Advisory Services sold 4,728 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2014, an estimated $208K.
Annex Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and held it in 1 quarter.
Annex Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $208K in Q4 2013.
72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2014.

Based on Annex Advisory Services's 13F filing for Q1 2014, filed 15 May 2014.